首页> 外国专利> RECEPTOR LSR ACTIVITY CLONING AND APPLICATIONS TO DIAGNOSIS PREVENTION AND / OR TREATMENT OF OBESITY AND ASSOCIATED RISKS OR COMPLICATIONS

RECEPTOR LSR ACTIVITY CLONING AND APPLICATIONS TO DIAGNOSIS PREVENTION AND / OR TREATMENT OF OBESITY AND ASSOCIATED RISKS OR COMPLICATIONS

机译:受体LSR活性的克隆及其在肥胖的预防和/或治疗以及相关风险或并发症的诊断中的应用

摘要

Purified LSR (lipolysis stimulated receptor) that binds lipoproteins (Lp) in presence of free fatty acids (FFA) and binds cytokines (Cy) in absence of FFA, is new. Independent claims are also included for the following: (1) purified, isolated or recombinant polypeptides (I) that make up LSR; (2) purified, isolated or recombinant nucleic acid (II) that encodes LSR or (I); (3) cloning and/or expression vectors containing (II); (4) host cells transformed with this vector; (5) non-human mammals containing a cell of (4); (6) recombinant production of (I); (7) mono- or poly-clonal or chimeric antibodies (Ab), or immunoconjugates that react specifically with (I) or LSR; (8) screening for (bio)chemicals (A) that interact with LSR; (9) (A); (10) use of Cy, specifically leptin, for modulating activity of LSR.
机译:纯化的LSR(脂解刺激受体)在游离脂肪酸(FFA)存在的情况下结合脂蛋白(Lp),在没有FFA的情况下结合细胞因子(Cy),是新的。还包括以下方面的独立权利要求:(1)组成LSR的纯化,分离或重组多肽(I); (2)纯化,分离或重组的编码LSR或(I)的核酸(II); (3)含有(II)的克隆和/或表达载体; (4)用该载体转化的宿主细胞; (5)含有(4)的细胞的非人类哺乳动物; (6)(I)的重组生产; (7)与(I)或LSR特异性反应的单克隆或多克隆或嵌合抗体(Ab),或免疫缀合物; (8)筛选与LSR相互作用的(生物)化学品(A); (9)(A); (10)使用Cy,特别是瘦蛋白,来调节LSR的活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号